Coronavirus COVID-19. COVID-19
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group in addition to drug treatment according to the Ministry of Health protocol, take 2 tablespoons of medium-chain triglyceride (MCT) to cure fev
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients with mild or moderate COVID-19 disease according to the diagnostic protocol provided by the Ministry of Health
Exclusion criteria
Exclusion criteria: No allergic to MCT (for those who have previously taken MCT and know they are allergic).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Temperature. Timepoint: 0-1-2-3-14 days after starting intervention. Method of measurement: Thermometer.;Cough (severity-frequency). Timepoint: 0-1-2-3-14 days after starting intervention. Method of measurement: Fisman Cough Severity Score.;Weakness. Timepoint: 0-1-2-3-14 days after starting intervention. Method of measurement: Asking patients using visual analog scale (VAS).;Respiratory rate. Timepoint: 0-1-2-3-14 days after starting intervention. Method of measurement: Counting the number of breaths per minute.;Muscular pain. Timepoint: 0-1-2-3-14 days after starting intervention. Method of measurement: Asking patients using visual analog scale (VAS).;Urine Ketone. Timepoint: Four hours after taking MCT oil. Method of measurement: It is checked with a urine test strip. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital admssion. Timepoint: 0-1-2-3-14 days after starting intervention. Method of measurement: Ratio of the number of admission to total patients in each group.;Mortality. Timepoint: 0-1-2-3-14 days after starting intervention. Method of measurement: Ratio of the number of deaths to total patients in each group. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Zahedi Neyestani
Kerman University of Medical Sciences
Outcome results
None listed